Over the years, our company always insist on market-oriented, taking the road of science and technology enterprises, increasing research funding, also successfully developed a series of chlorhexidine bulk drugs、National Category ⅡNew Drug--omeprazole, pantoprazole sodium bulk drugs and their formulations, metronidazole and furazolidone suppositories, sanwei hemorrhoids suppositories and other dozens of new product, which has six new drugs filled domestic blank. Four types of product sysytem are chlorhexidine-based disinfection materials, gynecology suppositories, anti-peptic ulcer drugs, antipyretic analgesics respectively. Since 2002, company invested tens of millions, joinly developed Natinal category new drug with Shenyang Pharmaceutical University, now Phase Ⅲ of clinical trial has finished, and has obtained patent authorization of U.S., Russia, China and the EU. With the sustained business conception of integrity -based, mutual development, our permanent principle that contracts are honored and commercial integrity is maintained. In the filed of business, the company has streamlined sales team, stable marketing network, product sales throught the country, and some of products have been exported to Europe and America.